Therapeutic Monitoring of Infliximab and Adalimumab

Clinical trial NCT06033469 · UNKNOWN

Trial details

NCT number: NCT06033469
Sponsor: IRCCS Burlo Garofolo
Status: UNKNOWN
Study type: OBSERVATIONAL

Inflammatory Bowel Diseases

Start date: 2018-03-15
Primary completion: 2024-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.